Michael Timaner

Platelet factor 4–induced T _H 1-T _reg polarization suppresses antitumor immunity

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

The Role of Caspase-4 and NLRP1 in MCF7 Cell Pyroptosis Induced by hUCMSC-Secreted Factors

A view on drug resistance in cancer

Inflammation and Cancer: Triggers, Mechanisms, and Consequences

A glitch in the matrix: organ-specific matrisomes in metastatic niches

Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer

Macrophages in immunoregulation and therapeutics

Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects

Inflammation and tumor progression: signaling pathways and targeted intervention

Targeting macrophages: therapeutic approaches in cancer

Pyroptosis: mechanisms and diseases

Dormant tumour cells, their niches and the influence of immunity

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

Multiple roles of lymphatic vessels in tumor progression

Chemotherapy-Induced Metastasis: Molecular Mechanisms, Clinical Manifestations, Therapeutic Interventions

Emerging roles for the IL-6 family of cytokines in pancreatic cancer

Lymphatic vessels in cancer

T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy

Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells

Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3

Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases

The multifaceted role of mesenchymal stem cells in cancer

The antiangiogenic role of the pro-inflammatory cytokine interleukin-31

Dequalinium blocks macrophage-induced metastasis following local radiation